We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Changes Course, Recommends Use of Contaminated Vaccines
FDA Changes Course, Recommends Use of Contaminated Vaccines
May 21, 2010
The FDA is advising resumed use of GlaxoSmithKline’s (GSK) Rotavirus vaccine Rotarix and the continued use of Merck’s vaccine Rotateq after an advisory panel voiced support for the contaminated vaccines.